| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L.; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:32Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-03T03:06:50Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu C.C.; Lin L.Y.; Lin L.C.; Huang H.C.; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; WEN-YIH TSENG; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K. |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:43Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
SUNG-CHUN TANG;Lin J.-L.;Hwang J.-J;Wu Y.-W;Yang Y.-C;Chan H.-L;Tsai L.-K;Fu W.-R;Chao A.-C;Lee M.-Y;Wang C.-Y;Huang W.-C;Chang W.-T;Chen Z.-C;Huang C.-W;Chen P.-W;Wu C.-K;Chang K.-C;Huang C.-C;Yeh H.-I;Wu C.-C;Wang Y.-C;Lin T.-H;Chen J.-W;Li Y.-H; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I; Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:30Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG;Yeh H.-I.;Li Y.-H;Huang Y.-H;Chen P.-S;Chien S.-C; Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-02-27T07:42:46Z |
2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
|
Chiang C.-E.; Wang T.-D.; Ueng K.-C.; Lin T.-H.; Yeh H.-I.; Chen C.-Y.; Wu Y.-J.; Tsai W.-C.; Chao T.-H.; Chen C.-H.; Chu P.-H.; Chao C.-L.; Liu P.-Y.; Sung S.-H.; Cheng H.-M.; Wang K.-L.; Li Y.-H.; Chiang F.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Lin S.-J.; Lin S.-J.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Chiang F.-T.;Li Y.-H.;Wang K.-L.;Cheng H.-M.;Sung S.-H.;Liu P.-Y.;Chao C.-L.;Chu P.-H.;Chen C.-H.;Chao T.-H.;Tsai W.-C.;Wu Y.-J.;Chen C.-Y.;Yeh H.-I.;Lin T.-H.;Ueng K.-C.;Wang T.-D.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:37Z |
The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension
|
Lin J.-L.; Lin J.-L.;Lin S.-J.;Chen M.-F.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Lai W.-T.;Chiang F.-T.;Wang K.-Y.;Li Y.-H.;Wang K.-L.;Sung S.-H.;Chu P.-H.;Chen C.-Y.;Ueng K.-C.;Shyu K.-G.;Chen C.-H.;Chao T.-H.;Cheng H.-M.;Liu P.-Y.;Yeh H.-I.;Lin T.-H.;Wang T.-D.;Chiang C.-E.; Chiang C.-E.; Wang T.-D.; Lin T.-H.; Yeh H.-I.; Liu P.-Y.; Cheng H.-M.; Chao T.-H.; Chen C.-H.; Shyu K.-G.; Ueng K.-C.; Chen C.-Y.; Chu P.-H.; Sung S.-H.; Wang K.-L.; Li Y.-H.; Wang K.-Y.; Chiang F.-T.; Lai W.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Chen M.-F.; Lin S.-J. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-01-13T08:21:29Z |
Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020-01-13T08:21:28Z |
Corrigendum to “Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users” [J. Mol. Cell. Cardiol. 114 (2018) 150–160](S0022282817303358)(10.1016/j.yjmcc.2017.10.011)
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; CHIH-YUAN WANG; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.; Chang K.-C.; Huang C.-C.; Yeh H.-I.; Wu C.-C.; Lin T.-H.; Wang Y.-C.; Chen J.-W.; Li Y.-H.; Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Chih-Yuan Wang;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L. |
